A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma

The benefits of adjuvant cytokine-induced killer (CIK) cell immunotherapy for hepatocellular carcinoma (HCC) remain mixed among patients. Here, we constructed a prognostic nomogram to enable individualized predictions of survival benefit of adjuvant CIK cell treatment for HCC patients. Survival anal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Pan, Qiu-Zhong, Wang, Qi-Jing, Dan, Jia-Qiang, Pan, Ke, Li, Yong-Qiang, Zhang, Yao-Jun, Zhao, Jing-Jing, Weng, De-Sheng, Tang, Yan, Huang, Li-Xi, He, Jia, Chen, Shi-Ping, Ke, Miao-La, Chen, Min-Shan, Wicha, Max S., Chang, Alfred E., Zeng, Yi-Xin, Li, Qiao, Xia, Jian-Chuan
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361845/
https://ncbi.nlm.nih.gov/pubmed/25776856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep09202
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars